Chest CT in COVID-19 Pneumonia: Potentials and Limitations of Radiomics and Artificial Intelligence
- Authors: Vernuccio F.; Cutaia G.; Cannella R.; Vernuccio L.; Lagalla R.; Midiri M.
- Publication year: 2022
- Type: Capitolo o Saggio
- OA Link: http://hdl.handle.net/10447/589695
Abstract
SARS-CoV-2 epidemics has resulted in an unprecedented global health crisis causing a high number of deaths with pneumonia being the most common manifestation. Chest CT is the best imaging modality to identify pulmonary involvement, but unfortunately there are no pathognomonic features for COVID-19 pneumonia, since many other infectious and non-infectious diseases may cause similar alterations. The adoption of artificial intelligence in biomedical imaging has the potential to revolutionize the identification, management, and the patient’s outcome. If adequately validated, it could be used as a support with predictive and prognostic purposes in symptomatic patients but also as a screening test in asymptomatic patients in COVID-19 epidemics. Some studies have already shown the potential adoption of artificial intelligence for detection of COVID-19 infection, or even to differentiate from community-acquired pneumonia, but at present artificial intelligence cannot routinely applied for COVID-19 due to several limitations. This book chapter will first revise the basics of radiomics with a short practical and easy guide for radiologists; then, the main radiological findings of COVID-19 pneumonia will be presented with the most relevant information that are assessed to evaluate extent of the disease; finally, the main current literature on potential clinical application of radiomics and artificial intelligence for COVID-19 will be presented together with limitations and perspectives.